- The stock price of Blueprint Medicines (NASDAQ: BPMC) fell by 9.99% today. This is why it happened.
The stock price of Blueprint Medicines (NASDAQ: BPMC) fell by 9.99% today. Investors are responding negatively to the company reporting a Q4 EPS of ($5.40), which was $3.75 less than analyst estimates of ($1.65). And revenue for the quarter was $107.02 million compared to the consensus estimate of $102.69 million.
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.
